Protocol-driven primary care and community linkage to reduce all-cause mortality in rural Zambia: a stepped-wedge cluster randomized trial.
health system strengthening
health systems
mortality
quality improvement
stepped wedge
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
04
2023
accepted:
03
07
2023
medline:
21
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
epublish
Résumé
While tremendous progress has been made in recent years to improve the health of people living in low- and middle-income countries (LMIC), significant challenges remain. Chief among these are poor health systems, which are often ill-equipped to respond to current challenges. It remains unclear whether intensive intervention at the health system level will result in improved outcomes, as there have been few rigorously designed comparative studies. We present results of a complex health system intervention that was implemented in Zambia using a cluster randomized design. BHOMA was a complex health system intervention comprising intensive clinical training and quality improvement measures, support for commodities procurement, improved community outreach, and district level management support. The intervention was introduced as a stepped wedge cluster-randomized trial in 42 predominately rural health centers and their surrounding communities in Lusaka Province, Zambia. Baseline survey was conducted between January-May 2011, mid-line survey was conducted February-November, 2013 and Endline survey, February-November 2015.The primary outcome was all-cause mortality among those between 28 days and 60 years of age and assessed through community-based mortality surveys. Secondary outcomes included post-neonatal under-five mortality and service coverage scores. Service coverage scores were calculated across five domains (child preventative services; child treatment services; family planning; maternal health services, and adult health services). We fit Cox proportional hazards model with shared frailty at the cluster level for the primary analysis. Mortality rates were age-standardized using the WHO World Standard Population. Mortality declined substantially from 3.9 per 1,000 person-years in the pre-intervention period, to 1.5 per 1,000 person-years in the post intervention period. When we compared intervention and control periods, there were 174 deaths in 49,230 person years (age-standardized rate = 4.4 per 1,000 person-years) in the control phase and 277 deaths in 74,519 person years (age-standardized rate = 4.6 per 1,000 person-years) in the intervention phase. Overall, there was no evidence for an effect of the intervention in minimally-adjusted [hazard ratio (HR) = 1.18; 95% confidence interval (CI): 0.88, 1.56; value of We noted an overall reduction in post-neonatal under 60 mortality in the study communities during the period of our study, but this could not be attributed to the BHOMA intervention. Some improvements in service coverage scores were observed. clinicaltrials.gov, Identifier NCT01942278.
Identifiants
pubmed: 37727608
doi: 10.3389/fpubh.2023.1214066
pmc: PMC10505962
doi:
Substances chimiques
Antimalarials
0
Banques de données
ClinicalTrials.gov
['NCT01942278']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1214066Informations de copyright
Copyright © 2023 Mutale, Ayles, Lewis, Bosompraph, Chilengi, Tembo, Sharp, Chintu and Stringer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Telemed J E Health. 2014 Aug;20(8):721-8
pubmed: 24926815
PLoS Med. 2009 Apr 28;6(4):e1000059
pubmed: 19399158
Am J Trop Med Hyg. 2016 Mar;94(3):571-573
pubmed: 26936992
Hum Resour Health. 2013 Feb 21;11:8
pubmed: 23433226
BMC Health Serv Res. 2013 Aug 01;13:291
pubmed: 23902601
BMC Health Serv Res. 2013;13 Suppl 2:S7
pubmed: 23819614
BMC Health Serv Res. 2018 Oct 19;18(1):795
pubmed: 30340583
PLoS One. 2019 Jun 12;14(6):e0218025
pubmed: 31188845
BMC Int Health Hum Rights. 2013 Aug 09;13:34
pubmed: 23927531
PLoS One. 2014 Apr 21;9(4):e93977
pubmed: 24751780
PLoS One. 2013;8(3):e58650
pubmed: 23555590
Soc Sci Med. 2010 Nov;71(10):1764-72
pubmed: 20541305
Lancet. 2005 Oct 22-28;366(9495):1460-6
pubmed: 16243091
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 2:S46-53
pubmed: 26115858
J Eval Clin Pract. 2016 Feb;22(1):112-121
pubmed: 24814988
BMC Public Health. 2015 Sep 24;15:960
pubmed: 26404638
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
BMC Public Health. 2015 Sep 21;15:933
pubmed: 26391985
BMJ Glob Health. 2018 Apr 09;3(2):e000674
pubmed: 29662695
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
BMC Health Serv Res. 2017 Feb 3;17(1):111
pubmed: 28158981
BMC Health Serv Res. 2017 Apr 17;17(1):279
pubmed: 28416009
Lancet. 2017 Sep 16;390(10100):1423-1459
pubmed: 28916366
Contemp Clin Trials. 2015 Nov;45(Pt A):55-60
pubmed: 26247569
BMJ Glob Health. 2018 Jun 04;3(3):e000762
pubmed: 29915670
J Eval Clin Pract. 2017 Apr;23(2):439-452
pubmed: 26011652
BMC Health Serv Res. 2013;13 Suppl 2:S9
pubmed: 23819699
Reprod Health. 2019 Jun 6;16(1):78
pubmed: 31171007
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
BMC Med. 2014 Jan 14;12:6
pubmed: 24423387
BMC Public Health. 2017 Mar 23;17(1):277
pubmed: 28335751
J Clin Epidemiol. 2019 Mar;107:89-100
pubmed: 30458261